Skip to main content

Gilead Sciences Invests in Research for COVID-19 Treatments for All Ages

By: 3BL Media

SOURCE: Gilead Sciences

DESCRIPTION:

Children are being hospitalized with COVID 19 at increasingly high rates, and those younger than 5 aren't eligible to receive a vaccine. We’re committed to helping in this area by investing in research for COVID-19 treatments for all ages.

About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences.

Tweet me: .@GileadSciences is committed to helping children being hospitalized with #COVID19 by investing in research for COVID-19 treatments for all ages. #CROI2022 https://bit.ly/3GNxutP

KEYWORDS: NASDAQ: GILD, COVID-19, CROI2022

Chart showing increase in COVID-19 hospitalizations among children in the US

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.01
-5.10 (-2.43%)
AAPL  266.27
+1.69 (0.64%)
AMD  195.87
-4.28 (-2.14%)
BAC  51.11
-1.95 (-3.68%)
GOOG  310.93
-3.97 (-1.26%)
META  637.03
-18.62 (-2.84%)
MSFT  383.97
-13.26 (-3.34%)
NVDA  191.25
+1.43 (0.75%)
ORCL  140.60
-7.48 (-5.05%)
TSLA  396.89
-14.93 (-3.63%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.